The company had placed its worldwide vaccine trials on hold for several days. It now says a safety review by regulators and reviewers is complete. No word on when studies in the U.S. might resume.
Earlier in the week, AstraZeneca had paused worldwide studies of its candidate vaccine after one U.K. participant developed symptoms consistent with the spinal cord inflammation known as transverse myelitis.Earlier in the week, AstraZeneca had paused worldwide studies of its candidate vaccine after one U.K. participant developed symptoms consistent with the spinal cord inflammation known as transverse myelitis.
Although initial studies didn't reveal serious side effects from the vaccine, rare complications of any vaccine, if there are any, may not turn up until it has been administered to thousands, or tens or thousands of people.all studies around the world of this particular candidate vaccine were paused after one volunteer in the U.K.
AstraZeneca said it cannot disclose further medical information because it is the study sponsor, but added in its statement,"All trial investigators and participants will be updated with the relevant information, and this will be disclosed on global clinical registries, according to the clinical trial and regulatory standards."
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
AstraZeneca Covid-19 Vaccine Trials Resume in U.K.The company has ended a pause in clinical trials for its experimental coronavirus vaccine in the U.K. after regulators concluded it was safe to do so. The trials were halted globally after a person who received the vaccine had an unexplained illness.
Weiterlesen »
DCGI orders suspension of Serum's India trials of AstraZeneca's COVID-19 vaccine: ANIIndia's drug regulator has asked Serum Institute of India to suspend recruitment in its clinical trials of AstraZeneca Plc's potential COVID-19 vaccine in the country until further orders, Reuters partner ANI reported on Friday.
Weiterlesen »
DCGI orders suspension of Serum's India trials of AstraZeneca's COVID-19 vaccine - ANIIndia's drug regulator has asked Serum Institute of India to suspend recruitment in its clinical trials of AstraZeneca Plc's potential COVID-19 vaccine in the country until further orders, Reuters partner ANI reported on Friday.
Weiterlesen »
Why AstraZeneca pausing its COVID-19 vaccine trial may be good newsAstraZeneca has temporarily put the brakes on its late-stage, global COVID-19 vaccine trial after a participant came down with what experts call an 'adverse event.' The promising vaccine candidate created by researchers at Oxford had been marching through rounds of clinical trials before word
Weiterlesen »
NIH director says it's 'reassuring' that AstraZeneca paused its COVID-19 vaccine trialsThe trials were halted after one study participant in the U.K. developed a neurological condition.
Weiterlesen »
AstraZeneca expects COVID vaccine result by year-end if trials resumeAstraZeneca should still know by year-end whether its experimental vaccine protects people against coronavirus, as long as it is cleared to resume trials soon, its chief executive said on Thursday amid doubts over its rollout.
Weiterlesen »